Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
35.00
0.00 (0.00%)
At close: Dec 29, 2025
Genus Market Cap
Genus has a market cap or net worth of $2.28 billion as of January 9, 2026. Its market cap has increased by 81.24% in one year.
Market Cap
2.28B
Enterprise Value
2.57B
Revenue
921.77M
Ranking
n/a
PE Ratio
86.17
Stock Price
$35.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 50.66M to 2.28B, an increase of 4,397.73%. That is a compound annual growth rate of 14.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.28B | -2.51% |
| Dec 31, 2025 | 2.34B | 83.34% |
| Dec 31, 2024 | 1.27B | -29.66% |
| Dec 29, 2023 | 1.81B | -22.93% |
| Dec 30, 2022 | 2.35B | -46.03% |
| Dec 31, 2021 | 4.36B | 17.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Glass House Brands | 711.87M |
| Elite Pharmaceuticals | 521.08M |
| Northwest Biotherapeutics | 409.64M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 386.18M |
| CytoDyn | 343.01M |
| Silence Therapeutics | 260.73M |